Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.

Sheba Study Debunks Link Between COVID-19 Vaccine and Infertility

debunking covid-19 vaccine and infertility
A new study from Sheba’s Gynecology and Maternity Center found no change in hormone levels among recipients of the Pfizer-BioNTech vaccine.

According to a new Sheba Medical Center study, COVID-19 vaccines have no notable impact on fertility in women. The study assessed levels of an ovarian reserve indicator called anti-Müllerian hormone (AMH) and found no notable difference after the vaccine was administered.

During the study, led by Prof. Jaron Rabinovici, Deputy Director of Sheba’s Gynecology and Maternity Center, 129 participants were administered both doses of the Pfizer-BioNTech COVID-19 vaccine. Hormone levels were measured three months before the first dose, as well as three months after, and compared. Participants were studied both overall and by age group.

Sheba researchers will continue to monitor participants to check for any long-term effects, and an additional follow-up study focusing on girls between the ages of 12 and 18 is planned.

Since COVID-19 vaccines first became available, some have expressed concerns about side effects. However, experts have long contradicted these claims, and Sheba’s latest study supports this conclusion. In fact, studies have indicated that COVID-19 infections could have a negative impact on fertility, underscoring the importance of receiving the vaccine.

Sheba and Mayo Clinic merge Data-Sharing Network
News May 18.
Sheba and Mayo Clinic Partner to Transform Patient Care Through an Innovative Data-Sharing Network
Sheba Medical Center has joined the Mayo Clinic Platform Connect, a global data-sharing network that aims to revolutionize healthcare. The groundbreaking platform provides a safe,…
Read More
Sheba Medical Center is working on enhancing patient safety with AI solutions.
News May 18.
Enhancing Patient Safety and Care with AI Solutions
With improving patient care a top priority, Sheba recognized technological innovation as an essential enabler of progress and transformation, with a particular emphasis on artificial…
Read More
IBD passport for patients with ulcerative colitis.
News May 17.
Meet the IBD Passport: A New Hope for Ulcerative Colitis and Crohn’s Disease Patients 
Ulcerative colitis (UC) and Crohn’s disease, the two most common forms of inflammatory bowel disease (IBD), can cause frustrating symptoms like diarrhea, abdominal pain, bloating,…
Read More